Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 1997. Start Trial.
Date Value
September 30, 2026 84.15%
August 31, 2026 84.15%
July 31, 2026 82.88%
June 30, 2026 82.20%
May 31, 2026 82.20%
April 30, 2026 82.20%
March 31, 2026 82.20%
February 28, 2026 82.20%
January 31, 2026 82.20%
December 31, 2025 82.20%
November 30, 2025 82.20%
October 31, 2025 82.20%
September 30, 2025 82.20%
August 31, 2025 82.20%
July 31, 2025 82.20%
June 30, 2025 82.20%
May 31, 2025 82.20%
April 30, 2025 82.20%
March 31, 2025 82.20%
February 28, 2025 82.20%
January 31, 2025 82.20%
December 31, 2024 82.20%
November 30, 2024 82.20%
October 31, 2024 82.20%
September 30, 2024 82.20%
Date Value
August 31, 2024 82.20%
July 31, 2024 82.20%
June 30, 2024 82.20%
May 31, 2024 82.20%
April 30, 2024 82.20%
March 31, 2024 82.20%
February 29, 2024 82.20%
January 31, 2024 82.20%
December 31, 2023 82.20%
November 30, 2023 82.20%
October 31, 2023 82.20%
September 30, 2023 82.20%
August 31, 2023 81.09%
July 31, 2023 80.18%
June 30, 2023 80.00%
May 31, 2023 80.00%
April 30, 2023 80.00%
March 31, 2023 80.00%
February 28, 2023 74.57%
January 31, 2023 73.12%
December 31, 2022 72.12%
November 30, 2022 68.37%
October 31, 2022 66.42%
September 30, 2022 61.68%
August 31, 2022 52.16%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%
Veru, Inc. 99.12%
Johnson & Johnson 18.44%
Eli Lilly & Co. 34.47%